
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cannabidiol inhibits priming-induced reinstatement of methamphetamine in REM sleep deprived rats
Saeideh Karimi‐Haghighi, Abbas Haghparast
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 82, pp. 307-313
Closed Access | Times Cited: 63
Saeideh Karimi‐Haghighi, Abbas Haghparast
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 82, pp. 307-313
Closed Access | Times Cited: 63
Showing 1-25 of 63 citing articles:
The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder
Yann Chye, Erynn Christensen, Nadia Solowij, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 119
Yann Chye, Erynn Christensen, Nadia Solowij, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 119
Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms
Ewa Galaj, Guo‐Hua Bi, Hongju Yang, et al.
Neuropharmacology (2019) Vol. 167, pp. 107740-107740
Open Access | Times Cited: 106
Ewa Galaj, Guo‐Hua Bi, Hongju Yang, et al.
Neuropharmacology (2019) Vol. 167, pp. 107740-107740
Open Access | Times Cited: 106
Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
Francisco Navarrete, María S. García‐Gutiérrez, Ani Gasparyan, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 59
Francisco Navarrete, María S. García‐Gutiérrez, Ani Gasparyan, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 59
Neuroimmune Mechanisms as Novel Treatment Targets for Substance Use Disorders and Associated Comorbidities
Mark D. Namba, Jonna M. Leyrer‐Jackson, Erin K. Nagy, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 56
Mark D. Namba, Jonna M. Leyrer‐Jackson, Erin K. Nagy, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 56
Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms
Claudia Calpe-López, María Pilar García-Pardo, M.A. Aguilar
Molecules (2019) Vol. 24, Iss. 14, pp. 2583-2583
Open Access | Times Cited: 70
Claudia Calpe-López, María Pilar García-Pardo, M.A. Aguilar
Molecules (2019) Vol. 24, Iss. 14, pp. 2583-2583
Open Access | Times Cited: 70
Cannabidiol and substance use disorder: Dream or reality
Saeideh Karimi‐Haghighi, Yasaman Razavi, Daniela Iezzi, et al.
Neuropharmacology (2022) Vol. 207, pp. 108948-108948
Open Access | Times Cited: 33
Saeideh Karimi‐Haghighi, Yasaman Razavi, Daniela Iezzi, et al.
Neuropharmacology (2022) Vol. 207, pp. 108948-108948
Open Access | Times Cited: 33
Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders
Ewa Galaj, Zheng‐Xiong Xi
CNS Drugs (2019) Vol. 33, Iss. 10, pp. 1001-1030
Open Access | Times Cited: 51
Ewa Galaj, Zheng‐Xiong Xi
CNS Drugs (2019) Vol. 33, Iss. 10, pp. 1001-1030
Open Access | Times Cited: 51
Cannabidiol modulates the expression of neuroinflammatory factors in stress‐ and drug‐induced reinstatement of methamphetamine in extinguished rats
Saeideh Karimi‐Haghighi, Leila Dargahi, Abbas Haghparast
Addiction Biology (2019) Vol. 25, Iss. 2
Closed Access | Times Cited: 48
Saeideh Karimi‐Haghighi, Leila Dargahi, Abbas Haghparast
Addiction Biology (2019) Vol. 25, Iss. 2
Closed Access | Times Cited: 48
Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals
Ewa Galaj, Zheng‐Xiong Xi
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 134-134
Open Access | Times Cited: 43
Ewa Galaj, Zheng‐Xiong Xi
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 134-134
Open Access | Times Cited: 43
Cannabidiol in the context of substance use disorder treatment: A systematic review
Victoria Paulus, Joël Billieux, Amine Benyamina, et al.
Addictive Behaviors (2022) Vol. 132, pp. 107360-107360
Closed Access | Times Cited: 27
Victoria Paulus, Joël Billieux, Amine Benyamina, et al.
Addictive Behaviors (2022) Vol. 132, pp. 107360-107360
Closed Access | Times Cited: 27
Sleep loss and addiction
Luis Angel López-Muciño, Fabio Garcı́a-Garcı́a, Jonathan Cueto‐Escobedo, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 141, pp. 104832-104832
Closed Access | Times Cited: 26
Luis Angel López-Muciño, Fabio Garcı́a-Garcı́a, Jonathan Cueto‐Escobedo, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 141, pp. 104832-104832
Closed Access | Times Cited: 26
Cannabidiol efficiently suppressed the acquisition and expression of methamphetamine-induced conditioned place preference in the rat
Mahsa Anooshe, Kiana Nouri, Saeideh Karimi‐Haghighi, et al.
Behavioural Brain Research (2021) Vol. 404, pp. 113158-113158
Closed Access | Times Cited: 29
Mahsa Anooshe, Kiana Nouri, Saeideh Karimi‐Haghighi, et al.
Behavioural Brain Research (2021) Vol. 404, pp. 113158-113158
Closed Access | Times Cited: 29
Sleep and Substance Use: Exploring Reciprocal Impacts and Therapeutic Approaches
Christopher Bolling, M. Elizabeth Cardoni, J. Todd Arnedt
Current Psychiatry Reports (2025)
Closed Access
Christopher Bolling, M. Elizabeth Cardoni, J. Todd Arnedt
Current Psychiatry Reports (2025)
Closed Access
Effects of cannabidiol on alcohol-related outcomes: A review of preclinical and human research.
Christina N. Nona, Christian S. Hendershot, Bernard Le Foll
Experimental and Clinical Psychopharmacology (2019) Vol. 27, Iss. 4, pp. 359-369
Open Access | Times Cited: 34
Christina N. Nona, Christian S. Hendershot, Bernard Le Foll
Experimental and Clinical Psychopharmacology (2019) Vol. 27, Iss. 4, pp. 359-369
Open Access | Times Cited: 34
Neuroprotective effect of chronic administration of cannabidiol during the abstinence period on methamphetamine-induced impairment of recognition memory in the rats
Yasaman Razavi, Ronak Shabani, Mehdi Mehdizadeh, et al.
Behavioural Pharmacology (2020) Vol. 31, Iss. 4, pp. 385-396
Closed Access | Times Cited: 32
Yasaman Razavi, Ronak Shabani, Mehdi Mehdizadeh, et al.
Behavioural Pharmacology (2020) Vol. 31, Iss. 4, pp. 385-396
Closed Access | Times Cited: 32
REM sleep deprivation before extinction or reinstatement alters methamphetamine reward memory via D1-like dopamine receptors
Kaveh Shahveisi, Nasrin Abdoli, Vahid Farnia, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 213, pp. 173319-173319
Closed Access | Times Cited: 17
Kaveh Shahveisi, Nasrin Abdoli, Vahid Farnia, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 213, pp. 173319-173319
Closed Access | Times Cited: 17
Differential Roles of Intra-accumbal Orexin Receptors in Acquisition and Expression of Methamphetamine-Induced Conditioned Place Preference in the Rats
Elahe Khosrowabadi, Saeideh Karimi‐Haghighi, Shole Jamali, et al.
Neurochemical Research (2020) Vol. 45, Iss. 9, pp. 2230-2241
Closed Access | Times Cited: 26
Elahe Khosrowabadi, Saeideh Karimi‐Haghighi, Shole Jamali, et al.
Neurochemical Research (2020) Vol. 45, Iss. 9, pp. 2230-2241
Closed Access | Times Cited: 26
Cannabidiol prevents priming- and stress-induced reinstatement of the conditioned place preference induced by cocaine in mice
Claudia Calpe-López, Ani Gasparyan, Francisco Navarrete, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 7, pp. 864-874
Closed Access | Times Cited: 23
Claudia Calpe-López, Ani Gasparyan, Francisco Navarrete, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 7, pp. 864-874
Closed Access | Times Cited: 23
At the intersection of sleep deficiency and opioid use: mechanisms and therapeutic opportunities
Mark K. Greenwald, Tabitha E.H. Moses, Timothy Roehrs
Translational research (2021) Vol. 234, pp. 58-73
Open Access | Times Cited: 21
Mark K. Greenwald, Tabitha E.H. Moses, Timothy Roehrs
Translational research (2021) Vol. 234, pp. 58-73
Open Access | Times Cited: 21
Use of Cannabis as a Harm Reduction Strategy Among People Who Use Drugs: A Cohort Study
Janice Mok, M‐J Milloy, Cameron Grant, et al.
Cannabis and Cannabinoid Research (2022) Vol. 8, Iss. 4, pp. 670-678
Open Access | Times Cited: 14
Janice Mok, M‐J Milloy, Cameron Grant, et al.
Cannabis and Cannabinoid Research (2022) Vol. 8, Iss. 4, pp. 670-678
Open Access | Times Cited: 14
Intra-Accumbal D1- But not D2-Like Dopamine Receptor Antagonism Reverses the Inhibitory Effects of Cannabidiol on Extinction and Reinstatement of Methamphetamine Seeking Behavior in Rats
Mahboobeh Mirmohammadi, Kiarash Eskandari, Morteza Koruji, et al.
Cannabis and Cannabinoid Research (2022) Vol. 9, Iss. 1, pp. 89-110
Closed Access | Times Cited: 14
Mahboobeh Mirmohammadi, Kiarash Eskandari, Morteza Koruji, et al.
Cannabis and Cannabinoid Research (2022) Vol. 9, Iss. 1, pp. 89-110
Closed Access | Times Cited: 14
Cannabidiol (CBD) reduces cocaine-environment memory in mice
Rose Chesworth, Tim Karl
Pharmacology Biochemistry and Behavior (2020) Vol. 199, pp. 173065-173065
Closed Access | Times Cited: 23
Rose Chesworth, Tim Karl
Pharmacology Biochemistry and Behavior (2020) Vol. 199, pp. 173065-173065
Closed Access | Times Cited: 23
Involvement of Hippocampal D1-Like Dopamine Receptors in the Inhibitory Effect of Cannabidiol on Acquisition and Expression of Methamphetamine-Induced Conditioned Place Preference
Kiana Nouri, Mahsa Anooshe, Saeideh Karimi‐Haghighi, et al.
Neurochemical Research (2021) Vol. 46, Iss. 8, pp. 2008-2018
Closed Access | Times Cited: 20
Kiana Nouri, Mahsa Anooshe, Saeideh Karimi‐Haghighi, et al.
Neurochemical Research (2021) Vol. 46, Iss. 8, pp. 2008-2018
Closed Access | Times Cited: 20
Cannabidiol modulates the METH-induced conditioned place preference through D2-like dopamine receptors in the hippocampal CA1 region
Amir Arash Hassanlou, Shole Jamali, Kimia RayatSanati, et al.
Brain Research Bulletin (2021) Vol. 172, pp. 43-51
Closed Access | Times Cited: 18
Amir Arash Hassanlou, Shole Jamali, Kimia RayatSanati, et al.
Brain Research Bulletin (2021) Vol. 172, pp. 43-51
Closed Access | Times Cited: 18
Cannabidiol prevents amphetamine relapse and modulates D1- and D2-receptor levels in mesocorticolimbic brain areas of rats
Vinícia Garzella Metz, Jéssica Leandra Oliveira da Rosa, Domênika Rubert Rossato, et al.
European Neuropsychopharmacology (2021) Vol. 50, pp. 23-33
Closed Access | Times Cited: 18
Vinícia Garzella Metz, Jéssica Leandra Oliveira da Rosa, Domênika Rubert Rossato, et al.
European Neuropsychopharmacology (2021) Vol. 50, pp. 23-33
Closed Access | Times Cited: 18